Effect of GFR on Plasma N-Terminal Connective Tissue Growth Factor (CTGF) Concentrations
Karin G. F. Gerritsen, Robbert J. Kok(Utrecht University), Roel Goldschmeding(University Medical Center Utrecht), Claire H. den Hoedt(University Medical Center Utrecht), Marinus A. van den Dorpel(Maasstad Ziekenhuis), Alferso C Abrahams, Peter J. Blankestijn(Utrecht University), Jaap A. Joles(University Medical Center Utrecht), Maarten P. Koeners(University Medical Center Utrecht), Amélie Dendooven(University of Antwerp), Tri Q. Nguyen(Utrecht University), Hilde P.E. Peters(Radboud University Nijmegen), Jack F.M. Wetzels(Radboud University Nijmegen)
Cited by 22
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461